Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11018167 | Urologic Oncology: Seminars and Original Investigations | 2018 | 11 Pages |
Abstract
In stage I seminoma, tumor size is the most valuable prognostic factor on which to base relapse risk and to counsel patients about adjuvant treatment. Large tumor size was defined quite inhomogenously among the included studies, so no distinct cutoff value for tumor size can be recommended. Other potential prognostic factors including rete testis invasion play a minor role in stage I seminoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Friedemann M.D., Frank M.D., Katrin Ph.D., Christian M.D., Stefanie Ph.D., Annabel M.D.,